Clinical Usefulness of the "MN Criteria" - the <i>Clostridioides difficile</i> Infection Severity Scoring System - in the Japanese Setting-Reference-Cited by-同舟云学术

Clinical Usefulness of the "MN Criteria" - the <i>Clostridioides difficile</i> Infection Severity Scoring System - in the Japanese Setting

Published:2023-01-01 Issue:1 Volume:62 Page:59-67
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Asaoka Minami¹,Horita Yasuhiro²,Wachino Chiharu²,Kondo Shuhei¹,Hotta Yuji³,Kataoka Tomoya²,Sanagawa Akimasa³,Hayakawa Tomoaki³,Nakamura Atsushi¹,Kimura Kazunori³

Affiliation:

1. Division of Infection Prevention and Control, Nagoya City University Hospital, Japan

2. Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Japan

3. Department of Pharmacy, Nagoya City University Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/62/1/62_9540-22/_pdf

Reference15 articles.

1. 1. McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66: 987-994, 2018.

2. 2. Balsells E, Filipescu T, Kyaw MH, Wiuff C, Campbell H, Nair H. Infection prevention and control of Clostridium difficile: a global review of guidelines, strategies, and recommendations. J Glob Health 6: 020410, 2016.

3. 3. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31: 431-455, 2010.

4. 4. Surawicz CM, Brandt LJ, Binion DG, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108: 478-498; quiz 499, 2013.

5. 5. Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20 (Suppl 2): 1-26, 2014.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Bezlotoxumab Against Clostridioides difficile Infection: A Case-Series Study at a University Hospital in Japan and Literature Review;Cureus;2023-08-01